Infinity Pharmaceuticals Inc Stock (OTC: INFI)

Infinity Pharmaceuticals Inc (OTC:INFI) Stock, Quote.Headers.trade-ideas

Infinity Pharmaceuticals

News

Intraday Update

Markets

Movers

Trading Ideas

AAOI

ACAX

AVTX

AXLA

CLDI

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CODA

DZSI

EIGR

FAZE

GRAB

ALPS ETF Trusthen & Steers Global Realty Majors ETF

MicroCloud Hologram Inc. - Ordinary Shares

HOLO

INFI

KULR

KXIN

MYNZ

NAVB

NWGL

RBLX

RCKT

REVG

SANA

SGML

SLRN

VEON

WKHS

ZVSA

Gainers


	Avalo Therapeutics, Inc.  (NASDAQ: AVTX) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company’s securities had closing bid price of $0.10/less for 10 consecutive trading days.


Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday&#39;s Mid-Day Session

Penny Stocks

Small Cap

AGTI

AKAN

ANGI

ARRY

ASLE

ASNS

AVXL

AXON

AZTA

BGLC

BIRD

BLFS

BNTC

BOOM

BROS

BRSH

CELH

CUTR

DBTX

DKNG

DOCS

DRUG

DXPE

EBET

EGHT

ELBM

EMKR

EXFY

FTCI

IDAI

ISPO

KBNT

KVHI

LPRO

LPSN

LPTV

LYFT

MGIH

MRTX

MVIS

NOTE

NRDY

NVEI

OFIX

OPRT

PALI

PLAG

PMTS

PMVP

PSTX

PUBM

RENB

SCPL

SEER

SMCI

SNCE

Sony Group Corporation American Depositary Shares

SONY

SOUN

TBLA

TDUP

TLRY

TNGX

TOST

TWOU

TYGO

UIHC

UPST

VERI

Gainers


	Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.


Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday&#39;s Session

Pre-Market Outlook

AMRS

ATNF

GMBL

SPRC

Gainers


	180 Life Sciences Corp.  (NASDAQ: ATNF) shares surged 109.2% to $1.58 in pre-market trading after falling over 6% on Tuesday.


Why EMCORE Shares Are Trading Higher By 17%; Here Are 20 Stocks Moving Premarket

Infinity Pharmaceuticals Inc

INFINITY PHARMS INC by Infinity Pharmaceuticals, Inc.

INFICON HOLDING AG U/ADR by Inficon Holding AG

INFINEX VENTURES INC by Infinex Ventures, Inc.

INFINITE ACQUISITION CORP ORD SHS CL A

Inficon Holding AG

INFINEON TECHS AG by Infineon Technologies AG

Infineon Technologies AG

INFINEON TECHS AG S/ADR by Infineon Technologies AG

Infinera Corp

INFINITE GROUP INC by Infinite Group, Inc.

Infinite Group Inc

INFINITE NETWORKS CORP by Infinite Networks Corp.

Infinite Networks Corp

INFINITE TECH CORP by Infinite Technology Corp.

Infinite technology Corp

Infinitecoin

Infinitii Ai Inc

Infinito Gold Ltd

INFINITUM COPPER CORP by INFINITUM COPPER CORP.

Infinitum Copper Corp

Infinity Bancorp

INFINITY LITHIUM CORP by INFINITY LITHIUM CORP LTD.

Infinity Lithium Corp Ltd

Infinity Mining Ltd

Infinity PAD

INFINITY STONE VENTRS CP by Infinity Stone Ventures Corp.

Infinity Stone Ventures Corp

Infinity Stone Ventures Corp Ordinary Shares - Class A (Sub Voting)

<h3>Gainers</h3>
<ul>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) shares increased by 23.7% to $0.04 during Wednesday's after-market session. Trading volume for this security closed at 3.2 million, accounting for 94.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.9 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) shares moved upwards by 15.55% to $1.04. The company's market cap stands at $2.1 million. </li>
<li>Longeveron Inc. - Subscription Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVNR#NASDAQ">LGVNR</a>) shares increased by 14.94% to $0.01. </li>
<li>Scinai Immunotherapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCNI#NASDAQ">SCNI</a>) shares increased by 11.45% to $1.46. Today's trading volume for this security ended up closing at 582.8K shares, which is 6319.1 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $5.3 million. </li>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) stock rose 10.86% to $0.25. Trading volume for this security closed at 94.4 million, accounting for 886.9% of its average full-day volume over the last 100 days. The company's market cap stands at $5.0 million. </li>
<li>NanoString Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSTG#NASDAQ">NSTG</a>) stock rose 10.55% to $1.99. The company's market cap stands at $94.6 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Kiromic BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) shares declined by 51.0% to $0.71 during Wednesday's after-market session. At the close, Kiromic BioPharma's trading volume reached 65.0K shares. This is 90.6% of its average volume over the last 100 days. </li>
<li>OKYO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKYO#NASDAQ">OKYO</a>) stock decreased by 25.26% to $1.48. At the close, OKYO Pharma's trading volume reached 62.9K shares. This is 26.7% of its average volume over the last 100 days. The company's market cap stands at $37.8 million. </li>
<li>Bionomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNOX#NASDAQ">BNOX</a>) stock declined by 22.35% to $1.39. Today's trading volume for this security ended up closing at 226.7K shares, which is 112.6 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $11.3 million. </li>
<li>Impel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMPL#NASDAQ">IMPL</a>) shares decreased by 12.05% to $0.73. At the close, Impel Pharmaceuticals's trading volume reached 281.1K shares. This is 31.6% of its average volume over the last 100 days. The company's market cap stands at $17.3 million. </li>
<li>Creative Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) stock fell 8.16% to $5.18. This security traded at a volume of 343.5K shares come close, making up 450.3% of its average volume over the last 100 days. The company's market cap stands at $7.4 million. </li>
<li>Joint (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYNT#NASDAQ">JYNT</a>) stock decreased by 7.49% to $8.65. The market value of their outstanding shares is at $126.9 million. The company's, Q2 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BNOX

CELZ

IMPL

JYNT

KRBP

LGVNR

NSTG

OKYO

RNAZ

SCNI

12 Health Care Stocks Moving In Wednesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Avalo Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avtx#NASDAQ">AVTX</a>) shares surged 68% to $0.2075. Avalo Therapeutics, on Sept 12, got notice from the Nasdaq as of Sept 11 the company&rsquo;s securities had closing bid price of $0.10/less for 10 consecutive trading days.</li>
<li>ZyVersa Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zvsa#NASDAQ">ZVSA</a>) gained 63.5% to $0.2101.</li>
<li>Rocket Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rckt#NASDAQ">RCKT</a>) rose 31.8% to $20.15 after the company announced that alignment has been reached with the FDA on the global Phase 2 pivotal trial of RP-A501 for Danon Disease.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) gained 22.2% to $0.1090.</li>
<li>Axcella Health Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/axla#NASDAQ">AXLA</a>) shares jumped 19.3% to $1.36 after jumping more than 59% on Tuesday.</li>
<li>Alset Capital Acquisition Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acax#NASDAQ">ACAX</a>) gained 19.1% to $10.60.</li>
<li>Ohmyhome Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/omh#NASDAQ">OMH</a>) gained 18.2% to $1.9147.</li>
<li>ECARX Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ecx#NASDAQ">ECX</a>) surged 16.8% to $3.5628.</li>
<li>VEON Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/veon#NASDAQ">VEON</a>) gained 16.4% to $19.30.</li>
<li>Super League Enterprise, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sle#NASDAQ">SLE</a>) shares gained 16.2% to $2.2650 after falling 40% on Tuesday.</li>
<li>DZS Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dzsi#NASDAQ">DZSI</a>) gained 15.3% to $2.11. DZS secured $29.7 million in financing.</li>
<li>HireRight Holdings Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hrt#NYSE">HRT</a>) climbed 14.8% to $10.05. HireRight plans additional $25 million share repurchase program.</li>
<li>Sigma Lithium Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgml#NASDAQ">SGML</a>) rose 13.7% to $36.54.</li>
<li>Navidea Biopharmaceuticals, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/navb#NYSE">NAVB</a>) gained 13.3% to $0.1050.</li>
<li>Workhorse Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wkhs#NASDAQ">WKHS</a>) shares rose 13.2% to $0.7199 after the company announced it has received IRS approval as a qualified manufacturer for the Commercial Clean Vehicle Credit.</li>
<li>GRI Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gri#NASDAQ">GRI</a>) gained 12.5% to $1.44.</li>
<li>FaZe Holdings Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/faze#NASDAQ">FAZE</a>) gained 11.5% to $0.2041 after declining 13% on Tuesday.</li>
<li>REV Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/revg#NYSE">REVG</a>) surged 9.2% to $14.07 after the company reported better-than-expected third-quarter financial results and raised FY23 net sales guidance above estimates.</li>
<li>Mainz Biomed N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mynz#NASDAQ">MYNZ</a>) rose 6% to $3.88 after the company announced topline results from its ColoFuture study.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>MicroCloud Hologram Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/holo#NASDAQ">HOLO</a>) shares tumbled 71% to $3.05.</li>
<li>Eiger BioPharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eigr#NASDAQ">EIGR</a>) shares dipped 52.5% to $0.3279 after the company announced its decision to discontinue the Phase 3 LIMT-2 study of peginterferon lambda in patients with chronic hepatitis delta.</li>
<li>Calidi Biotherapeutics (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cldi#NYSE">CLDI</a>) fell 42.5% to $4.60 following the company&rsquo;s public debut.</li>
<li>Wheels Up Experience Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/up#NYSE">UP</a>) tumbled 31.3% to $2.72.</li>
<li>KULR Technology Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kulr#NYSE">KULR</a>) fell 29% to $0.4129 as the company reported pricing of $2.5 million public offering of common stock.</li>
<li>MMTec, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mtc#NASDAQ">MTC</a>) fell 28.5% to $0.3950.</li>
<li>Evolution Petroleum Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/epm#NYSE">EPM</a>) fell 23% to $6.81 after reporting downbeat fourth-quarter results.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) declined 19% to $9.20.</li>
<li>Canopy Growth Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) shares fell 18.7% to $1.0887 after declining more than 20% on Tuesday.</li>
<li>Acelyrin, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/slrn#NASDAQ">SLRN</a>) fell 16.6% to $10.68. Morgan Stanley downgraded Acelyrin from Overweight to Equal-Weight and lowered the price target from $39 to $19.</li>
<li>Coda Octopus Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/coda#NYSE">CODA</a>) declined 16.2% to $6.27 following downbeat quarterly results.</li>
<li>Infinity Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/infi#NASDAQ">INFI</a>) tumbled 16% to $0.0707. Infinity Pharmaceuticals received a delisting determination letter from Nasdaq stating that the company&#39;s stock will be suspended on Sept. 14, unless it requests a review of this decision.</li>
<li>Nature Wood Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwgl#NASDAQ">NWGL</a>) shares fell 15.4% to $8.12. Nature Wood Group reported the pricing of its initial public offering of 750,000 American Depositary Shares at $9 per ADS.</li>
<li>GigaCloud Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gct#NASDAQ">GCT</a>) fell 14.7% to $11.29. GigaCloud Technology recently entered into an agreement as the stalking horse bidder to acquire substantially all assets of Noble House Home Furnishings for $85 million.</li>
<li>Nature Wood Group Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwgl#NASDAQ">NWGL</a>) shares declined 12% to $8.45.</li>
<li>Kaixin Auto Holdings (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kxin#NASDAQ">KXIN</a>) shares fell 9.2% to $0.2487. Kaixin Auto recently inked a non-binding acquisition term sheet with WM Motor.</li>
<li>Sana Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sana#NASDAQ">SANA</a>) fell 9% to $5.18. Sana Biotechnology spokesperson, at Morgan Stanley Healthcare Conference, said expects to file an IND filing for SC291 product candidate in autoimmune diseases in the fourth quarter.</li>
<li>WeWork Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/we#NYSE">WE</a>) fell 7.7% to $5.21 after jumping 87% on Tuesday.</li>
<li>Roblox Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/rblx#NYSE">RBLX</a>) tumbled 7.2% to $27.10.</li>
<li>Grab Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grab#NASDAQ">GRAB</a>) fell 7.2% to $3.5175 after Singapore&#39;s Land Transport Authority announced it will investigate the supply of taxi and ride-hailing services in connection with a a review of the point-to-point industry structure and regulatory framework.</li>
<li>Unity Software Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/u#NYSE">U</a>) fell 5.7% to $36.75.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/09/34536808/bitcoin-tops-26-000-toncoin-emerges-as-top-gainer"> Bitcoin Tops $26,000; Toncoin Emerges As Top Gainer</a>

Why Eiger BioPharmaceuticals Shares Are Trading Lower By 52%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) stock moved upwards by 54.3% to $0.19 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of 254.7 million shares, making up 2392.7% of its average full-day volume over the last 100 days. The company's market cap stands at $3.8 million. </li>
<li>Impel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMPL#NASDAQ">IMPL</a>) stock rose 51.99% to $0.84. Trading volume for this security as of 13:30 EST is 32.3 million, which is 3640.6% of its average full-day volume over the last 100 days. The company's market cap stands at $19.9 million. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) shares moved upwards by 40.46% to $0.18. Trading volume for this security as of 13:30 EST is 105.9 million, which is 4299.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.5 million. </li>
<li>Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) stock rose 36.88% to $20.93. Trading volume for Rocket Pharmaceuticals's stock is 18.9 million as of 13:30 EST. This is 3117.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.6 billion. </li>
<li>Novo Integrated Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVOS#NASDAQ">NVOS</a>) shares moved upwards by 32.16% to $0.51. As of 13:30 EST, this security is trading at a volume of 104.6 million shares, making up 269.5% of its average full-day volume over the last 100 days. The company's market cap stands at $81.1 million. </li>
<li>Nemaura Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) shares increased by 27.14% to $0.45. The current volume of 2.3 million shares is 1585.8% of Nemaura Medical's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $12.8 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Eiger BioPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EIGR#NASDAQ">EIGR</a>) shares fell 44.6% to $0.38 during Wednesday's regular session. Trading volume for Eiger BioPharmaceuticals's stock is 2.2 million as of 13:30 EST. This is 502.6% of its average full-day volume over the last 100 days. The company's market cap stands at $16.9 million. </li>
<li>Longeveron Inc. - Subscription Right (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGVNR#NASDAQ">LGVNR</a>) shares fell 37.16% to $0.01. Trading volume for this security as of 13:30 EST is 1.6 million, which is 335.8% of its average full-day volume over the last 100 days. </li>
<li>Mira Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MIRA#NASDAQ">MIRA</a>) stock fell 23.73% to $4.5. The market value of their outstanding shares is at $66.3 million. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) stock decreased by 17.56% to $0.07. Infinity Pharmaceuticals's stock is trading at a volume of 4.9 million shares as of 13:30 EST. This is 142.2% of its average full-day volume over the last 100 days. The company's market cap stands at $6.3 million. </li>
<li>Creative Medical Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELZ#NASDAQ">CELZ</a>) stock decreased by 16.4% to $5.15. As of 13:30 EST, Creative Medical Tech's stock is trading at a volume of 784.1K, which is 1027.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $7.3 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock decreased by 14.29% to $1.2. cbdMD's stock is trading at a volume of 133.5K shares as of 13:30 EST. This is 269.1% of its average full-day volume over the last 100 days. The company's market cap stands at $3.4 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MIRA

NMRD

NVOS

YCBD

12 Health Care Stocks Moving In Wednesday's Intraday Session

<h3>Gainers</h3>
<ul>
<li>Avalo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVTX#NASDAQ">AVTX</a>) shares rose 73.8% to $0.21 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.3 million. </li>
<li>Rocket Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>) stock rose 37.01% to $20.95. The company's market cap stands at $1.6 billion. </li>
<li>ZyVersa Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVSA#NASDAQ">ZVSA</a>) stock moved upwards by 26.53% to $0.16. The company's market cap stands at $5.0 million. </li>
<li>Axcella Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) stock moved upwards by 21.49% to $1.39. The market value of their outstanding shares is at $102.0 million. </li>
<li>Hoth Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOTH#NASDAQ">HOTH</a>) shares moved upwards by 18.28% to $3.17. The market value of their outstanding shares is at $10.4 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) stock rose 17.06% to $0.21. The market value of their outstanding shares is at $4.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Eiger BioPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EIGR#NASDAQ">EIGR</a>) shares decreased by 33.3% to $0.46 during Wednesday's pre-market session. The company's market cap stands at $20.3 million. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) stock declined by 16.97% to $0.07. The market value of their outstanding shares is at $6.3 million. </li>
<li>Sana Biotechnology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) shares declined by 12.13% to $5.0. The market value of their outstanding shares is at $984.7 million. </li>
<li>OKYO Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKYO#NASDAQ">OKYO</a>) shares fell 11.92% to $1.7. The market value of their outstanding shares is at $43.4 million. </li>
<li>Nuwellis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUWE#NASDAQ">NUWE</a>) stock decreased by 10.91% to $1.47. The market value of their outstanding shares is at $2.7 million. </li>
<li>Baudax Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BXRX#NASDAQ">BXRX</a>) shares declined by 10.62% to $0.33. The company's market cap stands at $3.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BXRX

HOTH

NUWE

TNON

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

The Company Does Not Plan To Request A Review Of The Panel&rsquo;s Decision

Biotech

Health Care

General

Infinity Pharmaceuticals Received A Delisting Determination Letter From Nasdaq Stating That The Company's Stock Will Be Suspended On September 14, Unless It Requests A Review Of This Decision

<h3>Gainers</h3>
<ul>
<li>Axcella Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) stock rose 14.4% to $0.52 during Tuesday's after-market session. Axcella Health's trading volume hit 61.8 million shares by close, accounting for 4940.4% of its average volume over the last 100 days. The company's market cap stands at $37.9 million. </li>
<li>Carmell Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) stock moved upwards by 8.69% to $4.0. The market value of their outstanding shares is at $92.3 million. </li>
<li>ContraFect (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFRX#NASDAQ">CFRX</a>) stock moved upwards by 8.08% to $0.79. The market value of their outstanding shares is at $8.4 million. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) shares rose 7.81% to $0.09. Infinity Pharmaceuticals's trading volume hit 290.2K shares by close, accounting for 8.9% of its average volume over the last 100 days. The company's market cap stands at $7.8 million. </li>
<li>Beyond Air (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) stock rose 7.42% to $3.04. The company's market cap stands at $96.4 million. </li>
<li>Healthcare Triangle (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HCTI#NASDAQ">HCTI</a>) stock moved upwards by 6.61% to $4.48. The company's market cap stands at $19.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>FibroGen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FGEN#NASDAQ">FGEN</a>) shares declined by 18.0% to $1.05 during Tuesday's after-market session. Trading volume for this security closed at 690.6K, accounting for 20.8% of its average full-day volume over the last 100 days. The company's market cap stands at $103.1 million. </li>
<li>TransCode Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RNAZ#NASDAQ">RNAZ</a>) stock decreased by 12.8% to $1.5. The market value of their outstanding shares is at $3.0 million. </li>
<li>Precipio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) stock fell 7.69% to $0.34. The market value of their outstanding shares is at $9.2 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock fell 7.47% to $3.72. The company's market cap stands at $138.2 million. </li>
<li>Vaccinex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCNX#NASDAQ">VCNX</a>) shares decreased by 6.83% to $0.21. The market value of their outstanding shares is at $14.6 million. </li>
<li>NanoVibronix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) shares declined by 6.81% to $1.37. The market value of their outstanding shares is at $2.2 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEON

CFRX

CTCX

FGEN

HCTI

NAOV

PRPO

VCNX

XAIR

12 Health Care Stocks Moving In Tuesday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>MSP Recovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIFW#NASDAQ">LIFW</a>) stock increased by 14.0% to $0.08 during Friday's after-market session. At the close, MSP Recovery's trading volume reached 118.4K shares. This is 18.3% of its average volume over the last 100 days. The market value of their outstanding shares is at $25.1 million. </li>
<li>SCWorx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WORX#NASDAQ">WORX</a>) stock increased by 8.35% to $0.23. The company's market cap stands at $3.7 million. </li>
<li>Adaptimmune Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAP#NASDAQ">ADAP</a>) stock moved upwards by 7.02% to $0.83. The company's market cap stands at $188.8 million. </li>
<li>Inhibikase Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IKT#NASDAQ">IKT</a>) stock increased by 6.66% to $2.24. The market value of their outstanding shares is at $11.9 million. </li>
<li>Axcella Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXLA#NASDAQ">AXLA</a>) stock rose 6.36% to $0.12. Axcella Health's trading volume hit 149.2K shares by close, accounting for 12.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.6 million. </li>
<li>SenesTech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNES#NASDAQ">SNES</a>) stock rose 6.23% to $0.68. The company's market cap stands at $2.0 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Scilex Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCLX#NASDAQ">SCLX</a>) stock declined by 10.9% to $2.93 during Friday's after-market session. Trading volume for this security closed at 51.0K, accounting for 9.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $436.7 million. </li>
<li>AEON Biopharma (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/AEON#AMEX">AEON</a>) stock decreased by 8.9% to $4.2. The company's market cap stands at $156.0 million. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) shares declined by 7.62% to $0.08. This security traded at a volume of 54.9K shares come close, making up 1.7% of its average volume over the last 100 days. The company's market cap stands at $7.3 million. </li>
<li>Clene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNN#NASDAQ">CLNN</a>) stock declined by 6.66% to $0.67. The company's market cap stands at $85.9 million. </li>
<li>Aptorum Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APM#NASDAQ">APM</a>) stock decreased by 6.37% to $2.06. At the close, Aptorum Gr's trading volume reached 72.8K shares. This is 604.7% of its average volume over the last 100 days. The market value of their outstanding shares is at $8.5 million. </li>
<li>Catalyst Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBIO#NASDAQ">CBIO</a>) shares fell 5.36% to $0.55. Trading volume for this security closed at 83.6K, accounting for 12.6% of its average full-day volume over the last 100 days. The company's market cap stands at $20.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADAP

CBIO

CLNN

LIFW

SCLX

SNES

WORX

12 Health Care Stocks Moving In Friday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Tivic Health Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIVC#NASDAQ">TIVC</a>) stock increased by 47.2% to $0.1 during Thursday's pre-market session. The company's market cap stands at $14.4 million. As per the news, the Q2 earnings report came out 3 days ago. </li>
<li>Advanced Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHI#NASDAQ">AHI</a>) shares rose 31.51% to $5.05. The company's market cap stands at $35.3 million. </li>
<li>Pliant Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLRX#NASDAQ">PLRX</a>) shares increased by 31.15% to $22.56. The market value of their outstanding shares is at $1.3 billion. </li>
<li>Modular Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODD#NASDAQ">MODD</a>) shares increased by 28.58% to $1.26. The company's market cap stands at $26.5 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Infinity Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) shares rose 16.54% to $0.13. The market value of their outstanding shares is at $11.6 million. </li>
<li>Shuttle Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) shares increased by 14.82% to $0.91. The market value of their outstanding shares is at $12.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>T2 Biosystems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTOO#NASDAQ">TTOO</a>) stock fell 24.4% to $0.43 during Thursday's pre-market session. The market value of their outstanding shares is at $143.4 million. </li>
<li>Novo Integrated Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVOS#NASDAQ">NVOS</a>) shares fell 19.11% to $0.15. The market value of their outstanding shares is at $21.7 million. </li>
<li>Strata Skin Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SSKN#NASDAQ">SSKN</a>) stock declined by 12.94% to $0.51. The market value of their outstanding shares is at $17.6 million. </li>
<li>Kronos Bio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRON#NASDAQ">KRON</a>) stock decreased by 12.43% to $1.41. The market value of their outstanding shares is at $82.2 million. </li>
<li>Calliditas Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CALT#NASDAQ">CALT</a>) stock decreased by 12.25% to $16.63. The company's market cap stands at $446.2 million. As per the press release, Q2 earnings came out today. </li>
<li>Aclarion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACON#NASDAQ">ACON</a>) stock fell 9.57% to $0.44. The company's market cap stands at $3.5 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

12 Health Care Stocks Moving In Thursday's Pre-Market Session

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Infinity Pharmaceuticals Inc

Infinity Pharmaceuticals Inc (INFI) Forecast

Infinity Pharmaceuticals Inc (OTC:INFI) Stock, Quote.Headers.trade-ideas